Page last updated: 2024-11-02

pindolol and Hypertension, Malignant

pindolol has been researched along with Hypertension, Malignant in 6 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.

Research Excerpts

ExcerptRelevanceReference
"Such infarction appears to give rise to a form of renovascular hypertension, the severity and sudden onset of which distinguishes it from renal fibrodysplasia, which is commonly observed in this age group."1.27Renal segmental infarction: a cause of reversible malignant hypertension. ( Corvol, P; Elkik, F; Idatte, JM; Ménard, J, 1984)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elkik, F1
Corvol, P1
Idatte, JM1
Ménard, J1
Waal-Manning, HJ1
Simpson, FO1
Nussberger, J1
Vetter, W1
Krayenbühl, HP1
Koaté, P1
Diouf, S1
Diouf, D1
Badiane, M1
Sarr, A1
Tebloev, KI1
Kharchenko, VI1
Dergacheva, IuG1
Kiseleva, NG1
Petraneva, EV1
Nasedkin, VS1
Pashedko, MA1
Baranova, OS1
Passa, P1
Masquet, C1
Cophignon, J1
Gourgon, R1
Bouvrain, Y1

Trials

1 trial available for pindolol and Hypertension, Malignant

ArticleYear
[Multicomponent therapy of severe arterial hypertension in a hospital].
    Sovetskaia meditsina, 1991, Issue:9

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; D

1991

Other Studies

5 other studies available for pindolol and Hypertension, Malignant

ArticleYear
Renal segmental infarction: a cause of reversible malignant hypertension.
    Journal of hypertension, 1984, Volume: 2, Issue:2

    Topics: Adult; Captopril; Diagnosis, Differential; Fibromuscular Dysplasia; Humans; Hypertension, Malignant;

1984
Letter: Paradoxical effect of pindolol.
    British medical journal, 1975, Jul-19, Volume: 3, Issue:5976

    Topics: Dose-Response Relationship, Drug; Humans; Hypertension; Hypertension, Malignant; Male; Middle Aged;

1975
[Proceedings: The effect of beta receptor treatment with pindolol on the plasma renin activity and the left-ventricular dynamics in essential hypertension].
    Schweizerische medizinische Wochenschrift, 1975, Nov-01, Volume: 105, Issue:44

    Topics: Adult; Cardiac Output; Female; Heart Rate; Heart Ventricles; Humans; Hypertension, Malignant; Male;

1975
[Use of a beta blocker--the LB 46--in the treatment of certain forms of arterial hypertension].
    Bulletin de la Societe medicale d'Afrique noire de langue francaise, 1975, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Aged; Drug Evaluation; Female; Humans; Hypertension; Hypertension, Malignant; Mal

1975
[The heart in acromegaly. Haemodynamic study].
    Archives des maladies du coeur et des vaisseaux, 1973, Volume: 66, Issue:12

    Topics: Acromegaly; Adult; Aged; Cardiac Output; Diabetes Mellitus; Dye Dilution Technique; Female; Glucagon

1973